Van der Poel HG - Search Results

1

External Validation of Two Nomograms Developed for ⁶⁸Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer ¹⁸F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?

Luiting HB, Remmers S, Meijer D, Vis AN, Donswijk M, Oprea-Lager DE, Emmett L, Rauscher I, Van der Poel HG, Roobol MJ, van Leeuwen PJ. Luiting HB, et al. Among authors: van leeuwen pj, van der poel hg. Eur Urol Open Sci. 2021 Apr 29;28:47-51. doi: 10.1016/j.euros.2021.04.002. eCollection 2021 Jun. Eur Urol Open Sci. 2021. PMID: 34337525 Free PMC article.

2

Perineal salvage prostatectomy for radiation resistant prostate cancer.

van der Poel HG, Beetsma DB, van Boven H, Horenblas S. van der Poel HG, et al. Among authors: van boven h. Eur Urol. 2007 Jun;51(6):1565-71; discussion 1572. doi: 10.1016/j.eururo.2006.08.011. Epub 2006 Aug 24. Eur Urol. 2007. PMID: 16949728

3

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH. van den Bergh RC, et al. Among authors: van der hoeven j, van der poel hg. BJU Int. 2010 Apr;105(7):956-62. doi: 10.1111/j.1464-410X.2009.08887.x. Epub 2009 Oct 8. BJU Int. 2010. PMID: 19817747

4

Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.

van der Poel HG, Buckle T, Brouwer OR, Valdés Olmos RA, van Leeuwen FW. van der Poel HG, et al. Among authors: van leeuwen fw. Eur Urol. 2011 Oct;60(4):826-33. doi: 10.1016/j.eururo.2011.03.024. Epub 2011 Apr 1. Eur Urol. 2011. PMID: 21458154

5

Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.

van Vugt HA, Roobol MJ, van der Poel HG, van Muilekom EH, Busstra M, Kil P, Oomens EH, Leliveld A, Bangma CH, Korfage I, Steyerberg EW. van Vugt HA, et al. Among authors: van der poel hg, van muilekom eh. BJU Int. 2012 Jul;110(2):180-7. doi: 10.1111/j.1464-410X.2011.10679.x. Epub 2011 Nov 23. BJU Int. 2012. PMID: 22112199

6

Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort.

van Vugt HA, Kranse R, Steyerberg EW, van der Poel HG, Busstra M, Kil P, Oomens EH, de Jong IJ, Bangma CH, Roobol MJ. van Vugt HA, et al. Among authors: van der poel hg. Eur J Cancer. 2012 Aug;48(12):1809-15. doi: 10.1016/j.ejca.2012.02.002. Epub 2012 Mar 7. Eur J Cancer. 2012. PMID: 22406050

7

Timing of curative treatment for prostate cancer: a systematic review.

van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M, Vickers A, van der Poel HG. van den Bergh RC, et al. Among authors: van der poel hg. Eur Urol. 2013 Aug;64(2):204-15. doi: 10.1016/j.eururo.2013.02.024. Epub 2013 Feb 22. Eur Urol. 2013. PMID: 23453419 Free PMC article. Review.

8

Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer.

KleinJan GH, van den Berg NS, Brouwer OR, de Jong J, Acar C, Wit EM, Vegt E, van der Noort V, Valdés Olmos RA, van Leeuwen FW, van der Poel HG. KleinJan GH, et al. Among authors: van den berg ns, van der poel hg, van leeuwen fw, van der noort v. Eur Urol. 2014 Dec;66(6):991-8. doi: 10.1016/j.eururo.2014.07.014. Epub 2014 Aug 3. Eur Urol. 2014. PMID: 25092539

9

The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.

van Stam MA, Aaronson NK, Pos FJ, Bosch JL, Kieffer JM, Tillier CN, van der Poel HG. van Stam MA, et al. Among authors: van der poel hg. Eur Urol. 2016 Nov;70(5):751-757. doi: 10.1016/j.eururo.2016.03.010. Epub 2016 Mar 22. Eur Urol. 2016. PMID: 27016464

10

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.

Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Mottet N. Cornford P, et al. Among authors: van der kwast th, van der poel hg. Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31. Eur Urol. 2017. PMID: 27591931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters